Tirzepatide is a synthetic peptide-based compound that acts as a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It has been studied in research contexts related to glucose regulation, metabolic signaling, insulin secretion, and energy balance. Supplied as a 30mg lyophilized powder in a vial.
Specifications:
Quantity: 30mg per vial
Form: Lyophilized powder
Purity: ≥98% (verified by HPLC, where supported by batch-specific documentation)
Storage: Store according to the manufacturer’s specifications and the applicable Certificate of Analysis. Protect from light and moisture.
Reconstitution: For laboratory research use only; follow validated laboratory handling procedures and product-specific documentation.
For research and educational use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. Certificate of Analysis available upon request, where available.
